APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cardiac Marker

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cardiac Marker Market Outlook and Growth Opportunities 2026

Report ID 173975080420 December 2025195 pages

Choose your research edition.

Industry ResearchCardiac Marker Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiac Marker Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Cardiac Marker Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiac Marker Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiac Marker Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Cardiac Marker market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cardiac Marker is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cardiac Marker is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cardiac Marker is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cardiac Marker market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cardiac Marker market include BG Medicine, Biomerieux, Critical Diagnostics, DiaDexus, HyTest, Lee BioSolutions, Response Biomedical, Roche Diagnostics and Siemens Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cardiac Marker market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cardiac Marker and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cardiac Marker sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cardiac Marker market size, projected growth trends, production technologies, key applications, and end-use industries.

Cardiac Marker Segment by Company

BG Medicine

Biomerieux

Critical Diagnostics

DiaDexus

HyTest

Lee BioSolutions

Response Biomedical

Roche Diagnostics

Siemens Healthcare

Singulex

Sunfory

Thermo Scientific

Trinity Biotech

Abbott

Cardiac Marker Segment by Type

BNP & NT-proBNP

Troponin (cTnI and cTnT)

Myogloblin

Creatine kinase (CK) MB

Others (hs-CRP, D-Dimer, etc.)

Cardiac Marker Segment by Application

Myocardial Infarction

Acute Coronary Syndrome

Atherosclerosis

Congestive Heart Failure

Others

Cardiac Marker Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Cardiac Marker status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Cardiac Marker market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cardiac Marker significant trends, drivers, influence factors in global and regions.

6. To analyze Cardiac Marker competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiac Marker market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiac Marker and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiac Marker.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cardiac Marker market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cardiac Marker industry.

Chapter 3: Detailed analysis of Cardiac Marker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Cardiac Marker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Cardiac Marker in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cardiac Marker Industry Trends Table 2. Cardiac Marker Industry Drivers Table 3. Cardiac Marker Industry Opportunities and Challenges Table 4. Cardiac Marker Industry Restraints Table 5. Global Cardiac Marker Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cardiac Marker Revenue Share by Company (2021-2026) Table 7. Global Cardiac Marker Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Cardiac Marker Sales Volume Share by Company (2021-2026) Table 9. Global Cardiac Marker Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Cardiac Marker Company Ranking, (2024-2026) & (USD Million) Table 11. Global Cardiac Marker Key Company Manufacturing Base & Headquarters Table 12. Global Cardiac Marker Company, Product Type & Application Table 13. Global Cardiac Marker Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Cardiac Marker by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of BNP & NT-proBNP Table 18. Significant Companies of Troponin (cTnI and cTnT) Table 19. Significant Companies of Myogloblin Table 20. Significant Companies of Creatine kinase (CK) MB Table 21. Significant Companies of Others (hs-CRP, D-Dimer, etc.) Table 22. Global Cardiac Marker Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Cardiac Marker Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Cardiac Marker Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Cardiac Marker Sales Volume Share by Type (2021-2026) Table 26. Global Cardiac Marker Sales Volume Share by Type (2027-2032) Table 27. Global Cardiac Marker Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Cardiac Marker Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Cardiac Marker Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Cardiac Marker Sales Value Share by Type (2021-2026) Table 31. Global Cardiac Marker Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Myocardial Infarction Table 33. Significant Companies of Acute Coronary Syndrome Table 34. Significant Companies of Atherosclerosis Table 35. Significant Companies of Congestive Heart Failure Table 36. Significant Companies of Others Table 37. Global Cardiac Marker Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Cardiac Marker Sales Volume by Application (2021-2026) & (K Units) Table 39. Global Cardiac Marker Sales Volume by Application (2027-2032) & (K Units) Table 40. Global Cardiac Marker Sales Volume Share by Application (2021-2026) Table 41. Global Cardiac Marker Sales Volume Share by Application (2027-2032) Table 42. Global Cardiac Marker Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Cardiac Marker Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Cardiac Marker Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Cardiac Marker Sales Value Share by Application (2021-2026) Table 46. Global Cardiac Marker Sales Value Share by Application (2027-2032) Table 47. Global Cardiac Marker Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Cardiac Marker Sales by Region (2021-2026) & (K Units) Table 49. Global Cardiac Marker Sales Market Share by Region (2021-2026) Table 50. Global Cardiac Marker Sales by Region (2027-2032) & (K Units) Table 51. Global Cardiac Marker Sales Market Share by Region (2027-2032) Table 52. Global Cardiac Marker Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Cardiac Marker Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Cardiac Marker Sales Value Share by Region (2021-2026) Table 55. Global Cardiac Marker Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Cardiac Marker Sales Value Share by Region (2027-2032) Table 57. Global Cardiac Marker Market Average Price (US$/Unit) by Region (2021-2026) Table 58. Global Cardiac Marker Market Average Price (US$/Unit) by Region (2027-2032) Table 59. Global Cardiac Marker Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Global Cardiac Marker Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Cardiac Marker Sales by Country (2021-2026) & (K Units) Table 62. Global Cardiac Marker Sales Market Share by Country (2021-2026) Table 63. Global Cardiac Marker Sales by Country (2027-2032) & (K Units) Table 64. Global Cardiac Marker Sales Market Share by Country (2027-2032) Table 65. Global Cardiac Marker Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Cardiac Marker Sales Value Market Share by Country (2021-2026) Table 67. Global Cardiac Marker Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Cardiac Marker Sales Value Market Share by Country (2027-2032) Table 69. BG Medicine Company Information Table 70. BG Medicine Business Overview Table 71. BG Medicine Cardiac Marker Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. BG Medicine Cardiac Marker Product Portfolio Table 73. BG Medicine Recent Development Table 74. Biomerieux Company Information Table 75. Biomerieux Business Overview Table 76. Biomerieux Cardiac Marker Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Biomerieux Cardiac Marker Product Portfolio Table 78. Biomerieux Recent Development Table 79. Critical Diagnostics Company Information Table 80. Critical Diagnostics Business Overview Table 81. Critical Diagnostics Cardiac Marker Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Critical Diagnostics Cardiac Marker Product Portfolio Table 83. Critical Diagnostics Recent Development Table 84. DiaDexus Company Information Table 85. DiaDexus Business Overview Table 86. DiaDexus Cardiac Marker Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. DiaDexus Cardiac Marker Product Portfolio Table 88. DiaDexus Recent Development Table 89. HyTest Company Information Table 90. HyTest Business Overview Table 91. HyTest Cardiac Marker Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. HyTest Cardiac Marker Product Portfolio Table 93. HyTest Recent Development Table 94. Lee BioSolutions Company Information Table 95. Lee BioSolutions Business Overview Table 96. Lee BioSolutions Cardiac Marker Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Lee BioSolutions Cardiac Marker Product Portfolio Table 98. Lee BioSolutions Recent Development Table 99. Response Biomedical Company Information Table 100. Response Biomedical Business Overview Table 101. Response Biomedical Cardiac Marker Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Response Biomedical Cardiac Marker Product Portfolio Table 103. Response Biomedical Recent Development Table 104. Roche Diagnostics Company Information Table 105. Roche Diagnostics Business Overview Table 106. Roche Diagnostics Cardiac Marker Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Roche Diagnostics Cardiac Marker Product Portfolio Table 108. Roche Diagnostics Recent Development Table 109. Siemens Healthcare Company Information Table 110. Siemens Healthcare Business Overview Table 111. Siemens Healthcare Cardiac Marker Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Siemens Healthcare Cardiac Marker Product Portfolio Table 113. Siemens Healthcare Recent Development Table 114. Singulex Company Information Table 115. Singulex Business Overview Table 116. Singulex Cardiac Marker Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Singulex Cardiac Marker Product Portfolio Table 118. Singulex Recent Development Table 119. Sunfory Company Information Table 120. Sunfory Business Overview Table 121. Sunfory Cardiac Marker Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Sunfory Cardiac Marker Product Portfolio Table 123. Sunfory Recent Development Table 124. Thermo Scientific Company Information Table 125. Thermo Scientific Business Overview Table 126. Thermo Scientific Cardiac Marker Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Thermo Scientific Cardiac Marker Product Portfolio Table 128. Thermo Scientific Recent Development Table 129. Trinity Biotech Company Information Table 130. Trinity Biotech Business Overview Table 131. Trinity Biotech Cardiac Marker Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Trinity Biotech Cardiac Marker Product Portfolio Table 133. Trinity Biotech Recent Development Table 134. Abbott Company Information Table 135. Abbott Business Overview Table 136. Abbott Cardiac Marker Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Abbott Cardiac Marker Product Portfolio Table 138. Abbott Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Cardiac Marker Distributors List Table 142. Cardiac Marker Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Cardiac Marker Product Image Figure 2. Global Cardiac Marker Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cardiac Marker Sales Value (2021-2032) & (US$ Million) Figure 4. Global Cardiac Marker Sales (2021-2032) & (K Units) Figure 5. Global Cardiac Marker Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Cardiac Marker Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. BNP & NT-proBNP Image Figure 10. Troponin (cTnI and cTnT) Image Figure 11. Myogloblin Image Figure 12. Creatine kinase (CK) MB Image Figure 13. Others (hs-CRP, D-Dimer, etc.) Image Figure 14. Global Cardiac Marker Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Cardiac Marker Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Cardiac Marker Sales Volume Share by Type (2021-2032) Figure 17. Global Cardiac Marker Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Cardiac Marker Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Cardiac Marker Sales Value Share by Type (2021-2032) Figure 20. Myocardial Infarction Image Figure 21. Acute Coronary Syndrome Image Figure 22. Atherosclerosis Image Figure 23. Congestive Heart Failure Image Figure 24. Others Image Figure 25. Global Cardiac Marker Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Cardiac Marker Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Cardiac Marker Sales Volume Share by Application (2021-2032) Figure 28. Global Cardiac Marker Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Cardiac Marker Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Cardiac Marker Sales Value Share by Application (2021-2032) Figure 31. Global Cardiac Marker Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 32. Global Cardiac Marker Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Cardiac Marker Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Cardiac Marker Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Cardiac Marker Sales Value (2021-2032) & (US$ Million) Figure 36. North America Cardiac Marker Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Cardiac Marker Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Cardiac Marker Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Cardiac Marker Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Cardiac Marker Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Cardiac Marker Sales Value (2021-2032) & (US$ Million) Figure 42. South America Cardiac Marker Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Cardiac Marker Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Cardiac Marker Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Cardiac Marker Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Cardiac Marker Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Cardiac Marker Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Cardiac Marker Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Cardiac Marker Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • BNP & NT-proBNP
  • Troponin (cTnI and cTnT)
  • Myogloblin
  • Creatine kinase (CK) MB
  • Others (hs-CRP, D-Dimer, etc.)
Applications
  • Myocardial Infarction
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Congestive Heart Failure
  • Others
Companies covered
  • BG Medicine
  • Biomerieux
  • Critical Diagnostics
  • DiaDexus
  • HyTest
  • Lee BioSolutions
  • Response Biomedical
  • Roche Diagnostics
  • Siemens Healthcare
  • Singulex
  • Sunfory
  • Thermo Scientific
  • Trinity Biotech
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cardiac Marker Sales Value (2021-2032)
  4. 1.2.2 Global Cardiac Marker Sales Volume (2021-2032)
  5. 1.2.3 Global Cardiac Marker Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Cardiac Marker Market Dynamics
  1. 2.1 Cardiac Marker Industry Trends
  2. 2.2 Cardiac Marker Industry Drivers
  3. 2.3 Cardiac Marker Industry Opportunities and Challenges
  4. 2.4 Cardiac Marker Industry Restraints
3 Cardiac Marker Market by Company
  1. 3.1 Global Cardiac Marker Company Revenue Ranking in 2025
  2. 3.2 Global Cardiac Marker Revenue by Company (2021-2026)
  3. 3.3 Global Cardiac Marker Sales Volume by Company (2021-2026)
  4. 3.4 Global Cardiac Marker Average Price by Company (2021-2026)
  5. 3.5 Global Cardiac Marker Company Ranking (2024-2026)
  6. 3.6 Global Cardiac Marker Company Manufacturing Base and Headquarters
  7. 3.7 Global Cardiac Marker Company Product Type and Application
  8. 3.8 Global Cardiac Marker Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Cardiac Marker Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Cardiac Marker Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Cardiac Marker Market by Type
  1. 4.1 Cardiac Marker Type Introduction
  2. 4.1.1 BNP & NT-proBNP
  3. 4.1.2 Troponin (cTnI and cTnT)
  4. 4.1.3 Myogloblin
  5. 4.1.4 Creatine kinase (CK) MB
  6. 4.1.5 Others (hs-CRP, D-Dimer, etc.)
  7. 4.2 Global Cardiac Marker Sales Volume by Type
  8. 4.2.1 Global Cardiac Marker Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Cardiac Marker Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Cardiac Marker Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Cardiac Marker Sales Value by Type
  12. 4.3.1 Global Cardiac Marker Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Cardiac Marker Sales Value by Type (2021-2032)
  14. 4.3.3 Global Cardiac Marker Sales Value Share by Type (2021-2032)
5 Cardiac Marker Market by Application
  1. 5.1 Cardiac Marker Application Introduction
  2. 5.1.1 Myocardial Infarction
  3. 5.1.2 Acute Coronary Syndrome
  4. 5.1.3 Atherosclerosis
  5. 5.1.4 Congestive Heart Failure
  6. 5.1.5 Others
  7. 5.2 Global Cardiac Marker Sales Volume by Application
  8. 5.2.1 Global Cardiac Marker Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Cardiac Marker Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Cardiac Marker Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Cardiac Marker Sales Value by Application
  12. 5.3.1 Global Cardiac Marker Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Cardiac Marker Sales Value by Application (2021-2032)
  14. 5.3.3 Global Cardiac Marker Sales Value Share by Application (2021-2032)
6 Cardiac Marker Regional Sales and Value Analysis
  1. 6.1 Global Cardiac Marker Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cardiac Marker Sales by Region (2021-2032)
  3. 6.2.1 Global Cardiac Marker Sales by Region: 2021-2026
  4. 6.2.2 Global Cardiac Marker Sales by Region (2027-2032)
  5. 6.3 Global Cardiac Marker Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Cardiac Marker Sales Value by Region (2021-2032)
  7. 6.4.1 Global Cardiac Marker Sales Value by Region: 2021-2026
  8. 6.4.2 Global Cardiac Marker Sales Value by Region (2027-2032)
  9. 6.5 Global Cardiac Marker Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Cardiac Marker Sales Value (2021-2032)
  12. 6.6.2 North America Cardiac Marker Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Cardiac Marker Sales Value (2021-2032)
  15. 6.7.2 Europe Cardiac Marker Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Cardiac Marker Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Cardiac Marker Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Cardiac Marker Sales Value (2021-2032)
  21. 6.9.2 South America Cardiac Marker Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Cardiac Marker Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Cardiac Marker Sales Value Share by Country, 2025 VS 2032
7 Cardiac Marker Country-level Sales and Value Analysis
  1. 7.1 Global Cardiac Marker Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cardiac Marker Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Cardiac Marker Sales by Country (2021-2032)
  4. 7.3.1 Global Cardiac Marker Sales by Country (2021-2026)
  5. 7.3.2 Global Cardiac Marker Sales by Country (2027-2032)
  6. 7.4 Global Cardiac Marker Sales Value by Country (2021-2032)
  7. 7.4.1 Global Cardiac Marker Sales Value by Country (2021-2026)
  8. 7.4.2 Global Cardiac Marker Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Cardiac Marker Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Cardiac Marker Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Cardiac Marker Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Cardiac Marker Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Cardiac Marker Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Cardiac Marker Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Cardiac Marker Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Cardiac Marker Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Cardiac Marker Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Cardiac Marker Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Cardiac Marker Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Cardiac Marker Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Cardiac Marker Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Cardiac Marker Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Cardiac Marker Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Cardiac Marker Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Cardiac Marker Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Cardiac Marker Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Cardiac Marker Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Cardiac Marker Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Cardiac Marker Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Cardiac Marker Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Cardiac Marker Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Cardiac Marker Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Cardiac Marker Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Cardiac Marker Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Cardiac Marker Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Cardiac Marker Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Cardiac Marker Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Cardiac Marker Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Cardiac Marker Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BG Medicine
  2. 8.1.1 BG Medicine Company Information
  3. 8.1.2 BG Medicine Business Overview
  4. 8.1.3 BG Medicine Cardiac Marker Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 BG Medicine Cardiac Marker Product Portfolio
  6. 8.1.5 BG Medicine Recent Developments
  7. 8.2 Biomerieux
  8. 8.2.1 Biomerieux Company Information
  9. 8.2.2 Biomerieux Business Overview
  10. 8.2.3 Biomerieux Cardiac Marker Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Biomerieux Cardiac Marker Product Portfolio
  12. 8.2.5 Biomerieux Recent Developments
  13. 8.3 Critical Diagnostics
  14. 8.3.1 Critical Diagnostics Company Information
  15. 8.3.2 Critical Diagnostics Business Overview
  16. 8.3.3 Critical Diagnostics Cardiac Marker Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Critical Diagnostics Cardiac Marker Product Portfolio
  18. 8.3.5 Critical Diagnostics Recent Developments
  19. 8.4 DiaDexus
  20. 8.4.1 DiaDexus Company Information
  21. 8.4.2 DiaDexus Business Overview
  22. 8.4.3 DiaDexus Cardiac Marker Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 DiaDexus Cardiac Marker Product Portfolio
  24. 8.4.5 DiaDexus Recent Developments
  25. 8.5 HyTest
  26. 8.5.1 HyTest Company Information
  27. 8.5.2 HyTest Business Overview
  28. 8.5.3 HyTest Cardiac Marker Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 HyTest Cardiac Marker Product Portfolio
  30. 8.5.5 HyTest Recent Developments
  31. 8.6 Lee BioSolutions
  32. 8.6.1 Lee BioSolutions Company Information
  33. 8.6.2 Lee BioSolutions Business Overview
  34. 8.6.3 Lee BioSolutions Cardiac Marker Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Lee BioSolutions Cardiac Marker Product Portfolio
  36. 8.6.5 Lee BioSolutions Recent Developments
  37. 8.7 Response Biomedical
  38. 8.7.1 Response Biomedical Company Information
  39. 8.7.2 Response Biomedical Business Overview
  40. 8.7.3 Response Biomedical Cardiac Marker Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Response Biomedical Cardiac Marker Product Portfolio
  42. 8.7.5 Response Biomedical Recent Developments
  43. 8.8 Roche Diagnostics
  44. 8.8.1 Roche Diagnostics Company Information
  45. 8.8.2 Roche Diagnostics Business Overview
  46. 8.8.3 Roche Diagnostics Cardiac Marker Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Roche Diagnostics Cardiac Marker Product Portfolio
  48. 8.8.5 Roche Diagnostics Recent Developments
  49. 8.9 Siemens Healthcare
  50. 8.9.1 Siemens Healthcare Company Information
  51. 8.9.2 Siemens Healthcare Business Overview
  52. 8.9.3 Siemens Healthcare Cardiac Marker Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Siemens Healthcare Cardiac Marker Product Portfolio
  54. 8.9.5 Siemens Healthcare Recent Developments
  55. 8.10 Singulex
  56. 8.10.1 Singulex Company Information
  57. 8.10.2 Singulex Business Overview
  58. 8.10.3 Singulex Cardiac Marker Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Singulex Cardiac Marker Product Portfolio
  60. 8.10.5 Singulex Recent Developments
  61. 8.11 Sunfory
  62. 8.11.1 Sunfory Company Information
  63. 8.11.2 Sunfory Business Overview
  64. 8.11.3 Sunfory Cardiac Marker Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sunfory Cardiac Marker Product Portfolio
  66. 8.11.5 Sunfory Recent Developments
  67. 8.12 Thermo Scientific
  68. 8.12.1 Thermo Scientific Company Information
  69. 8.12.2 Thermo Scientific Business Overview
  70. 8.12.3 Thermo Scientific Cardiac Marker Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Thermo Scientific Cardiac Marker Product Portfolio
  72. 8.12.5 Thermo Scientific Recent Developments
  73. 8.13 Trinity Biotech
  74. 8.13.1 Trinity Biotech Company Information
  75. 8.13.2 Trinity Biotech Business Overview
  76. 8.13.3 Trinity Biotech Cardiac Marker Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Trinity Biotech Cardiac Marker Product Portfolio
  78. 8.13.5 Trinity Biotech Recent Developments
  79. 8.14 Abbott
  80. 8.14.1 Abbott Company Information
  81. 8.14.2 Abbott Business Overview
  82. 8.14.3 Abbott Cardiac Marker Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Abbott Cardiac Marker Product Portfolio
  84. 8.14.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cardiac Marker Value Chain Analysis
  2. 9.1.1 Cardiac Marker Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cardiac Marker Sales Mode & Process
  6. 9.2 Cardiac Marker Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cardiac Marker Distributors
  9. 9.2.3 Cardiac Marker Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst